Skip to content

FUtian communiTy neUrological health Research in the Elderly

Community neurodegerative diseases research in the elderly

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400085444
Enrollment
Unknown
Registered
2024-06-07
Start date
2023-09-17
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neurodegenerative diseases

Interventions

Sponsors

The Eighth Affiliated Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 100 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for Parkinson's disease group: ? Age = 50 years old; ? Meets the clinical diagnostic criteria for Parkinson's disease published by MDS in 2015, with clinically confirmed or highly likely Parkinson's disease; ? Sign an informed consent form. Inclusion criteria for Alzheimer's disease group: ? Age = 50 years old; ? Meets the diagnostic criteria for Alzheimer's disease published by National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association(NINCDS-ADRDA) in 1984; ? Sign an informed consent form. Inclusion criteria for mild cognitive impairment group: ? Age = 60 years old; ? Meets the diagnostic criteria for mild cognitive impairment by NINCDS-ADRDA; ? Sign informed consent form.

Exclusion criteria

Exclusion criteria: Exclusion criteria for Parkinson's disease group: ? Clinical diagnosis of Parkinson's superimposed syndrome (including multiple system atrophy, progressive supranuclear palsy, Lewy body dementia, etc.); ? The presence of severe dementia and mental disorders prevents the completion of clinical evaluations. Exclusion criteria for Alzheimer's disease group: ? The presence of severe dementia and mental disorders that prevent the completion of clinical evaluation. Exclusion criteria for mild cognitive impairment group: ? The presence of severe dementia and mental disorders that prevent the completion of clinical evaluation.

Design outcomes

Primary

MeasureTime frame
MDS unified Parkinson disease rating scale(MDS-UPDRS);Mini-mental State Examination(MMSE);Montreal Cognitive Assessment Test(MOCA);Non-Motor Symptoms Scale(NMSS);

Secondary

MeasureTime frame
Self-Rating Depression Scale(SDS);Self-Rating Anxiety Scale(SAS);Neuropsychiatric Inventory(NPI);EuroQol Five Dimensions Questionnaire( EQ-5D);Epworth Sleepiness Scale(ESS);ability of daily living(ADL);Drooling Severity and Frequency Scale(DSFS);Swallowing Disturbance Questionnaire(SDQ);Pittsburgh sleep quality index(PSQI);Gastrointestinal Symptom Rating Scale(GSRS);Incontinence Questionnaire-Urinary Incontinence Short Form;

Countries

China

Contacts

Public ContactEnxiang Tao

The Eighth Affiliated Hospital, Sun Yat-sen University

taoex@mail.sysu.edu.cn+86 135 8056 9468

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026